Policy | February 01, 2026
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
The Union Budget 2026–27 accords strong priority to the upgradation and expansion of healthcare infrastructure and medical education
UK Prime Minister Keir Starmer praised the initiative, saying: “Unlocking opportunities for British businesses across the globe and delivering for working people back home is always the driving force behind my international engagements."
The successive PLI disbursements validate our disciplined execution and sustained commitment to strengthening India’s domestic pharmaceutical manufacturing capabilities
The new investment will fuel expansion of Avalon's Diagnostic Intelligence capabilities
The feature will be available across all Max Healthcare facilities, offering patients consistent and convenient access to services nationwide
This collaboration sets the stage for WuXi Biologics’ first integrated CRDMO center in the region
Dragon Copilot integrates generative AI, ambient listening, and natural language processing (NLP) to capture and document care directly
The quarter included three IPOs worth US$ 428 million and one Qualified Institutional Placement (QIP) worth US$ 88 million
Subscribe To Our Newsletter & Stay Updated
